Novo Nordisk reported a surge in earnings and revenue on Thursday as it continues to benefit from the popularity of its weight-loss drugs. However, the company is still struggling with raising the supply of the drugs to meet demand.
Source: finance.yahoo.com
Related posts:
Billionaire David Tepper Just Made a Once-in-a-Generation Bet on This Stock. Time to Buy?
Zuckerberg announces paid subscription service for Facebook and Instagram
Bitcoin Halving Will Stir Next Crypto Frenzy, Thai Exchange Says
1 Stock to Buy, 1 Stock to Sell This Week: Micron, Nike
It takes a lot less money to feel wealthy than to be it, survey finds